The Effectiveness of Henna Topical Formulation for the Prevention and Control of Hand-Foot Syndrome
Phase 2
Recruiting
- Conditions
- Condition 1: Malignant neoplasm Cancer. Condition 2: Malignant neoplasm Cancer.Malignant neoplasm of lipOther and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
- Registration Number
- IRCT20181230042179N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Cancer Patients Candidate for Capsitibine Therapy
Exclusion Criteria
Increased liver enzymes
increased blood creatinine
fever, and severe neutropenia that need to be stopped
Having Diabetes
Use of immunosuppressant and anti-inflammatory drugs
Having autoimmune diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Side effects. Timepoint: Once a week for up to two months after intervention. Method of measurement: NCI Criteria.
- Secondary Outcome Measures
Name Time Method